Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation

INTRODUCTION: The application of botulinum toxin type A (BoNTA) is accelerating, and this includes the uncontrolled cosmetic use of the BoNTA. Diffusion of BoNTA can disturb neuromuscular transmission in several surrounding and distant muscles and result in clinical manifestations similar to myasthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Punga, Anna Rostedt, Liik, Maarika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical and Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044641/
https://www.ncbi.nlm.nih.gov/pubmed/32140629
http://dx.doi.org/10.1016/j.cnp.2020.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044641/
https://www.ncbi.nlm.nih.gov/pubmed/32140629
http://dx.doi.org/10.1016/j.cnp.2020.01.002

Ejemplares similares